A Respiratory Therapist-Driven High-Flow Nasal Cannula Liberation Protocol at High Altitude.

Vista sencilla de ítem
dc.contributor.authorVásquez Hoyos, Pablo
dc.contributor.authorVilla Rosero, Yinna M.
dc.contributor.authorJaramillo-Bustamante, Juan C.
dc.contributor.authorGómez Lund, Oscar
dc.contributor.authorCarvajal, Cristóbal
dc.contributor.authorDíaz, Franco
dc.contributor.authorGonzález-Dambrauskas, Sebastián
dc.contributor.authorCaporal, Paula
dc.contributor.authorJabornisky, Roberto
dc.contributor.authorSerra, Alberto
dc.contributor.authorMonteverde-Fernandez, Nicolás
dc.coverage.spatialEstados Unidos
dc.date.accessioned2026-09-04T19:05:42Z
dc.date.available2026-09-04T19:05:42Z
dc.date.issued2026-08-26
dc.description.abstractBackground: High-flow nasal cannula (HFNC) liberation strategies in pediatric intensive care often transition patients directly from HFNC to room air. At high altitude, oxygen requirements may persist after flow-dependent respiratory support is no longer needed. We evaluated the association between a protocolized, respiratory therapist-driven HFNC liberation strategy and time to successful liberation from high-flow support in children with acute respiratory failure. Methods: We conducted a retrospective cohort study using prospectively collected LARed Network registry data from a tertiary PICU in Bogotá, Colombia (2,600 m altitude). In September 2022, the unit implemented an HFNC liberation strategy designed to separate persistent oxygen requirement from ongoing need for high-flow support. The primary analysis included the first HFNC episode per PICU admission from March 2018 to March 2025. The primary outcome was time to successful HFNC liberation. Kaplan-Meier curves and multivariable Cox regression were used; gamma log-link models were used for sensitivity analyses, including a prespecified bronchiolitis subgroup. Results: We included 1,086 PICU admissions, 627 before and 459 after implementation. Median HFNC duration decreased from 59.8 h (interquartile ranges [IQR] 34.7-91.4) to 53.1 h (IQR 32.3-80.5, P = .01). Kaplan-Meier analysis showed earlier HFNC liberation after implementation (log-rank P < .01). Implementation was associated with earlier liberation in adjusted Cox regression (hazard ratio 1.17, 95% CI 1.03-1.34, P = .02). PICU stay decreased from 4.7 days (IQR 3.2-6.9) to 4.0 days (IQR 2.9-5.8, P < .01). In bronchiolitis, implementation was associated with an 18.2% relative reduction in HFNC duration (95% CI 7.7-27.5%, P < .01). Conclusions: In a high-altitude PICU, a respiratory therapist-driven HFNC liberation strategy was associated with earlier liberation from high-flow support. A strategy that preserves oxygen delivery while testing tolerance of minimal flow may be useful in high-altitude settings
dc.description.sponsorshipN/A
dc.identifier.citationRespiratory Care(2026) pp. 1-6
dc.identifier.doihttps://doi.org/10.1177/19433654261472965
dc.identifier.issn0020-1324
dc.identifier.orcidhttps://orcid.org/0000-0003-4763-074X
dc.identifier.urihttps://hdl.handle.net/20.500.12254/7727
dc.language.isoen
dc.publisherSAGE Publications
dc.rightsAtribución-NoComercial-CompartirIgual 3.0 Chile (CC BY-NC-SA 3.0 CL)
dc.rights.urihttp://creativecommons.org/licenses/by-nc-sa/3.0/cl/
dc.subjecthigh-flow nasal cannula
dc.subjectliberation
dc.subjectpediatrics
dc.subjectpediatric intensive care
dc.subjectrespiratory failure
dc.subjecthigh altitude
dc.subjectoxygen therapy
dc.subjectrespiratory therapist–driven protocol
dc.titleA Respiratory Therapist-Driven High-Flow Nasal Cannula Liberation Protocol at High Altitude.
dc.typeArticle
Archivos
Bloque original
Mostrando 1 - 1 de 1
No hay miniatura disponible
Nombre:
vaìsquez-hoyos-et-al-2026-a-respiratory-therapist-_260819_120537.pdf
Tamaño:
629.25 KB
Formato:
Adobe Portable Document Format
Descargar
Bloque de licencias
Mostrando 1 - 1 de 1
No hay miniatura disponible
Nombre:
license.txt
Tamaño:
347 B
Formato:
Item-specific license agreed upon to submission
Descripción:
Descargar
Colecciones
Artículos de Revistas